UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.531

Sortiert nach

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

Breast cancer research and treatment, 2013-11, Vol.142 (2), p.381-388

2013

Link zum Volltext

Verfügbarkeit prüfen

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

JNCI : Journal of the National Cancer Institute, 2004-02, Vol.96 (4), p.326-331

2004

Link zum Volltext

Verfügbarkeit prüfen

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Clinical breast cancer, 2011-04, Vol.11 (2), p.82-92

2011

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial

Journal of clinical oncology, 2003-08, Vol.21 (16), p.3133-3140

2003

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Journal of clinical oncology, 2003-04, Vol.21 (8), p.1562-1573

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Clinical cancer research, 2013-07, Vol.19 (13), p.3693-3702

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Clinical breast cancer, 2016-02, Vol.16 (1), p.31-37

2016

Link zum Volltext

Verfügbarkeit prüfen

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

Breast cancer research and treatment, 2009-11, Vol.118 (2), p.361-367, Article 361

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer

Clinical cancer research, 2007-06, Vol.13 (11), p.3312-3319

2007

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2005-01, Vol.23 (1), p.133-141

2005

Link zum Volltext

Verfügbarkeit prüfen

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results

Human gene therapy, 2003-07, Vol.14 (11), p.1117-1123

2003

Link zum Volltext

Verfügbarkeit prüfen

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

The New England journal of medicine, 1993-03, Vol.328 (11), p.756-761

1993

Link zum Volltext

Verfügbarkeit prüfen

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

Journal of immunotherapy (1997), 2003-03, Vol.26 (2), p.163

2003

Link zum Volltext

Verfügbarkeit prüfen

Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma

Journal of immunotherapy (1997), 2003-03, Vol.26 (2), p.130

2003

Link zum Volltext

Verfügbarkeit prüfen

Selective dose escalation of chemoradiotherapy for esophageal cancer: Role of treatment intensification

Seminars in oncology, 2004-12, Vol.31 (6), p.13-19

2004

Link zum Volltext

Verfügbarkeit prüfen

A quarter century of suicide in a major urban jail: implications for community psychiatry

The American journal of psychiatry, 1995-07, Vol.152 (7), p.1077-1080

1995

Link zum Volltext

Verfügbarkeit prüfen

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

The lancet oncology, 2017-12, Vol.18 (12), p.1688-1700

2017

Link zum Volltext

Verfügbarkeit prüfen

A 28-Day Carbohydrate-Restricted Diet Improves Markers of Cardiovascular Disease in Professional Firefighters

Journal of strength and conditioning research, 2020-10, Vol.34 (10), p.2785-2792

2020

Link zum Volltext

Verfügbarkeit prüfen

Computed tomography in staging of patients with melanoma metastatic to the regional nodes

Annals of surgical oncology, 1997-07, Vol.4 (5), p.396-402

1997

Link zum Volltext

Verfügbarkeit prüfen

Chronic Expanding Hematoma within a Periprosthetic Breast Capsule

Plastic and reconstructive surgery (1963), 1996-06, Vol.97 (7), p.1469-1472

1996

Link zum Volltext

Verfügbarkeit prüfen

Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain

Clinical pharmacology and therapeutics, 1991-06, Vol.49 (6), p.674-684

1991

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

Blood, 1996-05, Vol.87 (9), p.3607-3614

1996

Link zum Volltext

Verfügbarkeit prüfen

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer : clinical and immunological effects

Cancer research (Chicago, Ill.), 1992-06, Vol.52 (11), p.3005-3010

1992

Link zum Volltext

Verfügbarkeit prüfen

Interleukin 1α Increases Serum Leptin Concentrations in Humans

The journal of clinical endocrinology and metabolism, 1997-09, Vol.82 (9), p.3084-3086

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.531

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.443)
Mit Volltextzugriff
(1.261)

Publikationsform

Artikel
(1.530)
Webseiten
(1)

Sprache

Englisch
(1.531)
Japanisch
(296)
Norwegisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The New England Journal Of Medicine
(84)
Jama : The Journal Of The American Medical Association
(39)
New England Journal Of Medicine
(31)
Journal Of Clinical Oncology
(26)
The Lancet
(23)
British Journal Of Haematology
(21)
Cancer
(21)
Circulation
(21)
Blood
(20)
Plos One
(20)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

Sunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label Trial

Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized Trial

Adjuvant Immunization of HLA-A2–Positive Melanoma Patients With a Modified gp100 Peptide Induces Peptide-Specific CD8+ T-Cell Responses

Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer

Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin Combined With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive, Early-Stage Breast Cancer

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

Phase I Trial of BAY 50-4798, an Interleukin-2–Specific Agonist in Advanced Melanoma and Renal Cancer

Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5

Randomized Phase III Trial of High-Dose Interleukin-2 Versus Subcutaneous Interleukin-2 and Interferon in Patients With Metastatic Renal Cell Carcinoma

Vaccination of women with metastatic breast cancer, using a costimulatory gene (CD80)-modified, HLA-A2-matched, allogeneic, breast cancer cell line: Clinical and immunological results

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma

Selective dose escalation of chemoradiotherapy for esophageal cancer: Role of treatment intensification

A quarter century of suicide in a major urban jail: implications for community psychiatry

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

A 28-Day Carbohydrate-Restricted Diet Improves Markers of Cardiovascular Disease in Professional Firefighters

Computed tomography in staging of patients with melanoma metastatic to the regional nodes

Chronic Expanding Hematoma within a Periprosthetic Breast Capsule

Effect of caffeine on ibuprofen analgesia in postoperative oral surgery pain

A Randomized Placebo-Controlled Trial of Recombinant Human Interleukin-11 in Cancer Patients With Severe Thrombocytopenia Due To Chemotherapy

Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer : clinical and immunological effects

Interleukin 1α Increases Serum Leptin Concentrations in Humans

Aktive Filter

Suchergebnisse filtern